Mashup Score:18
VJOncologyModulating the gut microbiome to improve immune checkpoint inhibitor efficacy - 1 week
Mashup Score:18
Twitter Feed: VJ Oncology
Mashup Score:11
VJOncologyImproving target identification in patients with advanced NSCLC via up-front ctDNA - 3 days
Mashup Score:11
Wanda Cui, MBBS, BMedSci, FRACP, Peter MacCallum Cancer Centre, Melbourne, Australia, talks on an investigation into improving target identification...
-
š„ @CuiWanda of @PeterMacCC talks on improving target identification in patients with advanced NSCLC via up-front ctDNA Watch: šhttps://t.co/KcwfrVP7VEš @IASLC #WCLC22 #LCSM #LungCancer - view on twitter
Mashup Score:8
VJOncologySteps to combat bias and microaggression in healthcare - 22 hours
Mashup Score:8
Narjust Duma, MD, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, provides an overview of steps can be...
-
š„ @NarjustFlorezMD of @DanaFarberNews @harvardmed discusses steps to combat bias and microaggression in healthcare Watch: šhttps://t.co/H8OITEzYNLš @ASCO #ASCO22 - view on twitter
More coverage:
#asco22
Mashup Score:5
VJOncologyVISION: tolerability of 177Lu-PSMA-617 by treatment exposure in patients with mCRPC - 5 days
Mashup Score:5
VISION (NCT03511664) was an international, open-label study of 177Lu-PSMA-617 in adults with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) previously...
-
š„ @DrScottTagawa of @WeillCornell @nyphospital discusses a VISION subgroup analysis: tolerability of 177Lu-PSMA-617 by treatment exposure in patients with mCRPC Watch: šhttps://t.co/wvuqTBh3Gqš @ASCO #ASCO22 - view on twitter
More coverage:
#asco22
Mashup Score:3
VJOncologyPersonalized medicine for patients with GISTs - 1 week
Mashup Score:3
Michael C. Heinrich, MD, OHSU Knight Cancer Institute, Portland, OR, reflects on emerging biomarkers in predicting treatment responses in...
-
š„ Michael Heinrich of @OHSUKnight talks on personalized medicine for patients with GISTs Watch: šhttps://t.co/scyUWAdPogš @ASCO #ASCO22 - view on twitter
More coverage:
#asco22
Mashup Score:3
VJOncologyChallenges in genomic testing for lung cancer - 1 week
Mashup Score:3
Miguel Garcia-Pardo, MD, Princess Margaret Cancer Center, Toronto, Canada, provides an overview of challenges associated with genomic testing in...
-
š„ Miguel Garcia-Pardo of @pmcancercentre discusses challenges in genomic testing for lung cancer Watch: šhttps://t.co/5W5MmVm2THš @ASCO #ASCO22 #LCSM #LungCancer - view on twitter
Mashup Score:2
VJOncologyLung Cancer Archives | VJOncology - 1 week
Mashup Score:2
Welcome to the Lung Channel. Explore the latest updates in lung cancer, including expert interviews from major international congresses and news by...
-
It was lovely to meet FranƧoise Galateau Salle from @CLCCLeonBerard at #WCLC22 to chat about the diagnosis and future treatment of mesothelioma Interview coming soon to @VJOncology š https://t.co/VnQA0pd296 #LCsm #NSCLC #SCLC #Mesothelioma @IASLC https://t.co/VnQA0pd296 - view on twitter
Mashup Score:2
VJOncologySue S. Yom, MD, PhD, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, discusses the randomised Phase...
-
š„ Sue Yom of @UCSFCancer discusses āāNRG-HN002: chemoradiotherapy for p16-positive low-risk HPV-associated oropharyngeal carcinoma Watch: šhttps://t.co/ogmkfxIvlRš @ASCO #ASCO22 #HeadAndNeckCancer #HNCSM - view on twitter
Mashup Score:2
VJOncologyLung Cancer Archives | VJOncology - 1 week
Mashup Score:2
Welcome to the Lung Channel. Explore the latest updates in lung cancer, including expert interviews from major international congresses and news by...
-
Thank you to @HendriksLizza and @TizianaVavala for joining us for a roundtable discussion here at #WCLC22 covering oligometastatic disease and KRAS Session coming soon to @VJOncology: https://t.co/VnQA0pd296 #LCsm #NSCLC #SCLC #Mesothelioma @IASLC https://t.co/VnQA0pd296 - view on twitter
Mashup Score:2
VJOncologyLungIMPACT: impact of immediate AI enabled patient triage to chest CT on the lung cancer pathway - 3 days
Mashup Score:2
David Baldwin, MD, FRCP, Nottingham University Hospitals NHS Trust, Nottingham, UK, provides an overview of the LungIMPACT study investigating...
-
š„ David Baldwin of @nottmhospitals talks on LungIMPACT: impact of immediate AI enabled patient triage to chest CT on the lung cancer pathway Watch: šhttps://t.co/NWoVXVNv2Gš @IASLC #WCLC22 #LCSM #LungCancer - view on twitter
Nazli Dizman, MD, Yale University School of Medicine, New Haven, CT, talks on the association of the gut microbiome...
š„ @NazliDizman of @YaleIMed talks on modulating the gut microbiome to improve immune checkpoint inhibitor efficacy Watch: šhttps://t.co/K5T0AZEHiuš @ASCO #ASCO22 - view on twitter